Embedded Files
Our vision is to cure all children with high-risk neuroblastoma using novel precision therapies developed by our expert network of laboratory and clinical investigators.
NANT is an established international collaboration between neuroblastoma experts in children's cancer centers across North America, Europe and Australia.
We’re discovering why neuroblastoma outsmarts today’s treatments and then using that knowledge to design the next generation of therapies.
NANT is the only consortium solely dedicated to early phase trials of new treatments for relapsed/refractory high-risk neuroblastoma for over 25 years.
Currently Open Trials:
25th Annual NANT/PPG Investigators Meeting
On October 27, 2025 investigators from NANT and the associated Program Project Grant (PPG) met in Philadelphia, PA, hosted by NANT/PPG member Children’s Hospital of Philadelphia (CHOP). Investigators from across North America and collaborating sites in the United Kingdom and Europe as well as members of the Parent Advisory Committee (PAC) attended this three day meeting. The annual in person meeting provides an essential forum to promote exchange and discussion of clinical and research data and generate collaborative ideas for future research. This collaboration from “bench to bedside” and parent/family input facilitates rapid translation of novel research findings into clinical trials that can benefit patients.
Google Sites
Report abuse